| pubmed-article:17297432 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17297432 | lifeskim:mentions | umls-concept:C0041044 | lld:lifeskim |
| pubmed-article:17297432 | lifeskim:mentions | umls-concept:C0149904 | lld:lifeskim |
| pubmed-article:17297432 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:17297432 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:17297432 | lifeskim:mentions | umls-concept:C1710276 | lld:lifeskim |
| pubmed-article:17297432 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:17297432 | pubmed:dateCreated | 2007-2-13 | lld:pubmed |
| pubmed-article:17297432 | pubmed:abstractText | Trimethoprim-Sulfomethoxazole (TMP-SMX) related hepatotoxicity and associated severe systemic reaction are not frequent and documented only in case reports. We report a case of a 30-year-old man, who underwent a 15-day therapy with TMP-SMX for urinary tract infection and two weeks later developed acute cholestatic hepatitis, fever and a skin rash followed by severe systemic reaction. He was admitted in Intensive Care unit and with supportive therapy and prednisolone administration, he showed subsequent improvement over a period of few days. He had fully recovered months later. All tests for other causes of liver disease were negative and his liver biopsy showed evidence of drug-induced hepatic injury. | lld:pubmed |
| pubmed-article:17297432 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17297432 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17297432 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17297432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17297432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17297432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17297432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17297432 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17297432 | pubmed:issn | 1665-2681 | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:NikolaidisNN | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:ZhangE JEJ | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:NakosAA | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:PehlivanidisA... | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:KouklakisGG | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:MolyvasEE | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:MoschosJJ | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:KoulaouzidisA... | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:MpoumponarisA... | lld:pubmed |
| pubmed-article:17297432 | pubmed:author | pubmed-author:IosiphidisMM | lld:pubmed |
| pubmed-article:17297432 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17297432 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:17297432 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17297432 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17297432 | pubmed:pagination | 63-5 | lld:pubmed |
| pubmed-article:17297432 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:meshHeading | pubmed-meshheading:17297432... | lld:pubmed |
| pubmed-article:17297432 | pubmed:articleTitle | Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole. | lld:pubmed |
| pubmed-article:17297432 | pubmed:affiliation | Gastroenterology and Hepatology Department, 424 Army Hospital, Thessaloniki, Greece. | lld:pubmed |
| pubmed-article:17297432 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17297432 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17297432 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17297432 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17297432 | lld:pubmed |
